MAPK9 and cancer: In the early phase of cancer, the upregulation of DUSP1 enables tumors to evade SAPK-induced death, while in the advanced stages of cancer, the downregulation of DUSP1 promotes cell proliferation, increases tumor growth, and actuates the metastatic process39–44.